Evidence map›Paper›PMID 24889229›Full record

ArticleVirology2014

Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein.

Clayton R Morrison, Frank Scholle

Open access · greenAbstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Viruses · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Structure-guided insights on the role of NS1 in flavivirus infection.BioEssays : news and reviews in molecular, cellular and developmental biology · 2015
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Clayton R MorrisonDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA.
Frank ScholleDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA. Electronic address: frank_scholle@ncsu.edu.
North Carolina State University · US

Funding

Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEMPOWSKI, GREGORY D · 2003 to 2013
$91.4M
NIAID NIH HHS U54 AI057157NIAID NIH HHS U54AI057157-07
6 · The paper itself

Abstract

West Nile virus (WNV) is a mosquito-transmitted pathogen, which causes significant disease in humans. The innate immune system is a first-line defense against invading microorganism and many flaviviruses, including WNV, have evolved multifunctional proteins, which actively suppress its activation and antiviral actions. The WNV non-structural protein 1 (NS1) inhibits signal transduction originating from Toll-like receptor 3 (TLR3) and also critically contributes to virus genome replication. In this study we developed a novel FACS-based screen to attempt to separate these two functions. The individual amino acid changes P320S and M333V in NS1 restored TLR3 signaling in virus-infected HeLa cells. However, virus replication was also attenuated, suggesting that the two functions are not easily separated and may be contained within overlapping domains. The residues we identified are completely conserved among several mosquito- and tick-borne flaviviruses, indicating that they are of biological importance to the virus.

Indexed as

Host-Pathogen InteractionsImmune EvasionVirus ReplicationAmino Acid SubstitutionDNA Mutational AnalysisHeLa CellsHumansMutant ProteinsToll-Like Receptor 3Viral Nonstructural ProteinsWest Nile virusMutant Proteinsnonstructural protein 1, West Nile virusTLR3 protein, humanToll-Like Receptor 3Viral Nonstructural ProteinsFlavivirusInnate immunityNS1TLR3West Nile virus

Identifiers

PMID24889229
PMCPMC4044628
OpenAlexW2095015093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.